
Ligand Pharmaceuticals Inc
NASDAQ:LGND

Wall Street
Price Targets
LGND Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LGND
is 146.75 USD
with a low forecast of 136.35 USD and a high forecast of 164.85 USD.
Operating Income
Forecast
Operating Income Estimate
Ligand Pharmaceuticals Inc
For the last 13 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's operating income is
21%.
The projected
CAGR
for the next 3 years is
82%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LGND's stock price target?
Price Target
146.75
USD
According to Wall Street analysts, the average 1-year price target for
LGND
is 146.75 USD
with a low forecast of 136.35 USD and a high forecast of 164.85 USD.
What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
18%
For the last 13 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
18%.
What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
82%
For the last 13 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's operating income is
21%.
The projected
CAGR
for the next 3 years is
82%.